Skip to content
FIND A HEALTH VALLEY ACTOR
Lonza

Lonza to invest CHF 1 billion over 3 years in its Swiss sites

31.01.2019
Share this article

“Lonza invests 12% of its sales revenue in its plants” in Visp (VS).

 

Marc Funk will replace Richard Ridinger as CEO of Lonza as of 1 March 2019. He tells Patrice Delaye, from Bilan, how this investment will be used to support Lonza’s move from chemistry to biotechnology based services.

 

Read Magazine Bilan’s exclusive interview in French